Soluble urokinase plasminogen activator receptor (suPAR) is a novel independent predictive marker of myocardial infarction in HIV‐1‐infected patients: a nested case‐control study

摘要

ObjectivesPatients infected with HIV are at increased risk of myocardial infarction (MI). Increased plasma levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) have been associated with increased risk of cardiovascular diseases (CVD), including MI in the general population. We tested suPAR as a predictive biomarker of MI in HIV‐1‐infected individuals.